Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy

Thrombosis Research

Volumn 124, Issue 5, 2009, Pages 588-591

  Gremmel, Thomas ^a   Steiner, Sabine ^a   Seidinger, Daniela ^a   Koppensteiner, Renate ^a   Panzer, Simon ^a   Kopp, Christoph W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aspirin; Clopidogrel; Platelet inhibition; Smoking

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; PURINERGIC P2Y12 RECEPTOR; T ASS; UNCLASSIFIED DRUG;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CELL ASSAY; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY STENT; FEMALE; HUMAN; IN VITRO STUDY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SMOKING HABIT; STENT; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS;

AGED; ASPIRIN; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; SMOKING; TICLOPIDINE;

EID: 70349868299     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.06.012     Document Type: Article

References (25)

1. Cattaneo M. P2Y12 receptor antagonists: a rapidly expanding group of antiplatelet agents. Eur Heart J 27 9 (2006) 1010-1012
2. Sharis P.J., Cannon C.P., and Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med 129 5 (1998) 394-405
3. Gurbel P.A., Bliden K.P., Hiatt B.L., and O'Connor C.M. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 107 23 (2003) 2908-2913
4. Grossmann R., Sokolova O., Schnurr A., Bonz A., Porsche C., Obergfell A., et al. Variable extent of clopidogrel responsiveness in patients after coronary stenting. Thromb Haemost 92 6 (2004) 1201-1206
5. Serebruany V.L., Steinhubl S.R., Berger P.B., Malinin A.I., Bhatt D.L., and Topol E.J. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 45 2 (2005) 246-251
6. Geisler T., Langer H., Wydymus M., Gohring K., Zurn C., Bigalke B., et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J 27 20 (2006) 2420-2425
7. Frere C., Cuisset T., Quilici J., Camoin L., Carvajal J., Morange P.E., et al. ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome. Thromb Haemost 98 4 (2007) 838-843
8. Cuisset T., Frere C., Quilici J., Barbou F., Morange P.E., Hovasse T., et al. High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes. Thromb Haemost 97 2 (2007) 282-287
9. Gurbel P.A., Bliden K.P., Guyer K., Cho P.W., Zaman K.A., Kreutz R.P., et al. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 46 10 (2005) 1820-1826
10. Hochholzer W., Trenk D., Bestehorn H.P., Fischer B., Valina C.M., Ferenc M., et al. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol 48 9 (2006) 1742-1750
11. Matetzky S., Shenkman B., Guetta V., Shechter M., Bienart R., Goldenberg I., et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109 25 (2004) 3171-3175
12. Ambrose J.A., and Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43 10 (2004) 1731-1737
13. Fusegawa Y., and Handa S. Platelet aggregation induced by ADP or epinephrine is enhanced in habitual smokers. Thromb Res 97 5 (2000) 287-295
14. Shanker G., Kontos J.L., Eckman D.M., Wesley-Farrington D., and Sane D.C. Nicotine upregulates the expression of P2Y12 on vascular cells and megakaryoblasts. J Thromb Thrombolysis 22 3 (2006) 213-220
15. Bliden K.P., Dichiara J., Lawal L., Singla A., Antonino M.J., Baker B.A., et al. The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. J Am Coll Cardiol 52 7 (2008) 531-533
16. Price M.J., Endemann S., Gollapudi R.R., Valencia R., Stinis C.T., Levisay J.P., et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 29 8 (2008) 992-1000
17. Gremmel T., Steiner S., Seidinger D., Koppensteiner R., Panzer S., and Kopp C.W. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation. Thromb Haemost (2009)
18. Paniccia R., Antonucci E., Gori A.M., Marcucci R., Giglioli C., Antoniucci D., et al. Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients. J Thromb Haemost 5 9 (2007) 1839-1847
19. Tantcheva-Poor I., Zaigler M., Rietbrock S., and Fuhr U. Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics 9 2 (1999) 131-144
20. Yousef A.M., Arafat T., Bulatova N.R., and Al-Zumyli R. Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel. J Clin Pharm Ther 33 4 (2008) 439-449
21. McAdam B.F., Byrne D., Morrow J.D., and Oates J.A. Contribution of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers. Circulation 112 7 (2005) 1024-1029
22. Addad F., Chakroune T., Asma A., Abderazek F., Zohra D., Ghrissi I., et al. Clopidogrel but not Aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease. Thromb Res 123 4 (2009) 640-643
23. Buonamici P., Marcucci R., Migliorini A., Gensini G.F., Santini A., Paniccia R., et al. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 49 24 (2007) 2312-2317
24. Saraff K.Y., Steinhubl S.R., Hsu A.P., and Topol E.J. Smoking influences the effectiveness of dual antiplatelet therapy on long-term outcomes following percutaneous coronary intervention (abstr). J Am Coll Cardiol 47 (2006) 36B
25. Mishkel G.J., Moore A.L., Markwell S., and Shelton M.E. Correlates of late and very late thrombosis of drug eluting stents. Am Heart J 156 1 (2008) 141-147